The Danish National Genome Center Partners with Lifebit to Deliver Nationwide Personalised Medicine

The Danish National Genome Center has awarded Lifebit a four-year contract to implement Lifebit’s Federated Trusted Research Environment software, Lifebit CloudOS, within Denmark’s national supercomputing center. Lifebit, whose leading technology enables secure analysis over sensitive datasets for researchers and interconnects such large patient cohorts worldwide, today announces a long-term partnership with the Danish National…

thaipr.net

29 เม.ย. 65

Zimmer Biomet’s mymobility is recognized as “The Care Management Initiative of the Year” by the 2022 Healthcare Asia Medtech Awards

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that the company’s mymobility® digital care management platform won “The Care Management Initiative of the Year” award at this year’s Healthcare Asia Medtech Awards. mymobility® is a digital care management platform that uses iPhone® and Apple Watch® or Android devices […]

thaipr.net

28 เม.ย. 65

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV […]

thaipr.net

27 เม.ย. 65

Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress

As part of its ongoing commitment to the global bleeding disorders community, Octapharma is pleased to be a Gold Sponsor of the upcoming World Federation of Haemophilia (WFH) 2022 World Congress, taking place from May 8 to 11, 2022. This continues Octapharma’s long history of involvement and support of the WFH World Congress and the […]

thaipr.net

26 เม.ย. 65

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

Terran to advance the development of two of Sanofi’s Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commercialization in all fields of use Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Sanofi S.A. […]

thaipr.net

22 เม.ย. 65
1 73 74 75 76 77 128